MedPath

Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction after Coronary Stenting, A Randomized Controlled Trial

Phase 4
Conditions
Ischemic heart disease
Registration Number
JPRN-UMIN000005597
Lead Sponsor
Department of Cardiovascular Medicine Kyushu University Graduate School of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
260
Inclusion Criteria

Not provided

Exclusion Criteria

Statisfy even one of the conditions below. (1)Not completed all planned PCI. (2)Participant of other clinical trial interfering with this study. (3)Chronic dialysis, chronic liver cirrhosis. (4)Severely impaired LV function, EF<30%. (5)Contraindication for statins or ezetimibe.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath